These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 25822802)

  • 1. Down-regulated E-cadherin expression is associated with poor five-year overall survival in bone and soft tissue sarcoma: results of a meta-analysis.
    Wang N; He YL; Pang LJ; Zou H; Liu CX; Zhao J; Hu JM; Zhang WJ; Qi Y; Li F
    PLoS One; 2015; 10(3):e0121448. PubMed ID: 25822802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of E-cadherin in bone and soft tissue sarcomas: a possible role in epithelial differentiation.
    Sato H; Hasegawa T; Abe Y; Sakai H; Hirohashi S
    Hum Pathol; 1999 Nov; 30(11):1344-9. PubMed ID: 10571515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
    Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
    Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Soluble Neural-cadherin as a novel biomarker for malignant bone and soft tissue tumors.
    Niimi R; Matsumine A; Iino T; Nakazora S; Nakamura T; Uchida A; Sudo A
    BMC Cancer; 2013 Jun; 13():309. PubMed ID: 23799912
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dysadherin expression as a significant prognostic factor and as a determinant of histologic features in synovial sarcoma: special reference to its inverse relationship with E-cadherin expression.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Kawai A; Sonobe H; Takahira T; Kobayashi C; Yamamoto H; Tamiya S; Hirohashi S; Iwamoto Y; Tsuneyoshi M
    Am J Surg Pathol; 2007 Jan; 31(1):85-94. PubMed ID: 17197923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic significance of dysadherin expression in epithelioid sarcoma and its diagnostic utility in distinguishing epithelioid sarcoma from malignant rhabdoid tumor.
    Izumi T; Oda Y; Hasegawa T; Nakanishi Y; Iwasaki H; Sonobe H; Goto H; Kusakabe H; Takahira T; Kobayashi C; Kawaguchi K; Saito T; Yamamoto H; Tamiya S; Iwamoto Y; Tsuneyoshi M
    Mod Pathol; 2006 Jun; 19(6):820-31. PubMed ID: 16557275
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone versus soft-tissue sarcomas in the elderly.
    Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
    J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of FDG-PET in the detection, grading and response to therapy of soft tissue and bone sarcomas; a systematic review and meta-analysis.
    Bastiaannet E; Groen H; Jager PL; Cobben DC; van der Graaf WT; Vaalburg W; Hoekstra HJ
    Cancer Treat Rev; 2004 Feb; 30(1):83-101. PubMed ID: 14766127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.
    Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R
    Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Expression of intercellular adhesion molecules in epithelioid sarcoma and malignant rhabdoid tumor.
    Saito T; Oda Y; Itakura E; Shiratsuchi H; Kinoshita Y; Oshiro Y; Tamiya S; Hachitanda Y; Iwamoto Y; Tsuneyoshi M
    Pathol Int; 2001 Jul; 51(7):532-42. PubMed ID: 11472566
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Positron emission tomography (18)F-fluorodeoxyglucose uptake and prognosis in patients with bone and soft tissue sarcoma: A meta-analysis.
    Li YJ; Dai YL; Cheng YS; Zhang WB; Tu CQ
    Eur J Surg Oncol; 2016 Aug; 42(8):1103-14. PubMed ID: 27189833
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic and clinicopathological significance of downregulated E-cadherin expression in patients with non-small cell lung cancer (NSCLC): a meta-analysis.
    Yang YL; Chen MW; Xian L
    PLoS One; 2014; 9(6):e99763. PubMed ID: 24978478
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Analysis of clinicopathological characteristics and prognostic factors of foot and ankle soft tissue and bone tumors].
    Zhang XX; Xu LB; Xu SF; Zhao ZG; Liu T; Zhang SG; Yu SJ
    Zhonghua Zhong Liu Za Zhi; 2018 Sep; 40(9):685-689. PubMed ID: 30293395
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of p16(INK4a) is associated with reduced patient survival in soft tissue tumours, and indicates a senescence barrier.
    Knösel T; Altendorf-Hofmann A; Lindner L; Issels R; Hermeking H; Schuebbe G; Gibis S; Siemens H; Kampmann E; Kirchner T
    J Clin Pathol; 2014 Jul; 67(7):592-8. PubMed ID: 24747207
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analysis of downregulated E-cadherin as a poor prognostic biomarker for cervical cancer.
    Peng J; Qi S; Wang P; Li W; Song L; Liu C; Li F
    Future Oncol; 2016 Mar; 12(5):715-26. PubMed ID: 26653706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
    Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
    BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic role of elevated preoperative systemic inflammatory markers in localized soft tissue sarcoma.
    Li Y; Liu X; Zhang J; Yao W
    Cancer Biomark; 2016; 16(3):333-42. PubMed ID: 26835589
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic significance of (18)F-FDG PET at diagnosis in patients with soft tissue sarcoma and bone sarcoma; systematic review and meta-analysis.
    Kubo T; Furuta T; Johan MP; Ochi M
    Eur J Cancer; 2016 May; 58():104-11. PubMed ID: 26990930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic value of myogenic differentiation in undifferentiated pleomorphic sarcomas of soft tissue.
    Cipriani NA; Kurzawa P; Ahmad RA; Deshpande V; Hornicek FJ; Mullen JT; Nielsen GP
    Hum Pathol; 2014 Jul; 45(7):1504-8. PubMed ID: 24780826
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and prognostic significance of PD-1 and PD-L1 expression in sarcomas.
    Paydas S; Bagir EK; Deveci MA; Gonlusen G
    Med Oncol; 2016 Aug; 33(8):93. PubMed ID: 27421997
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.